Hypophysis Precursor Tissue Differentiation via Floating Aggregates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack a viable approach to induce differentiation of stem cells into pituitary precursor tissue and various pituitary hormone-producing cells in vitro, particularly for treating hormone-related disorders.

Innovation Solution

A method involving the formation of aggregates of stem cells in a serum-free medium, followed by floating-culture using specific signal promoters like Shh and BMP, to induce differentiation into both central nervous tissue and non-neural head ectodermal tissue, specifically targeting the development of rostral hypothalamus and pituitary precursor tissues, and further promoting the production of pituitary hormones.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional nerve differentiation methods are used for pluripotent stem cells, then neural tissue differentiation is achieved, but pituitary precursor tissue differentiation cannot be induced

Engineering Contradiction:
ImproveDifferentiation capability into pituitary precursor tissueVSAvoidDifferentiation efficiency
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The differentiation process is segmented into distinct phases: first forming aggregates of pluripotent stem cells, then inducing neural differentiation to create central nervous tissue within the aggregate, and finally inducing ectodermal differentiation to create non-neural head ectoderm tissue. This segmentation allows each tissue type to develop under optimized conditions, enabling pituitary precursor tissue formation that conventional single-phase methods cannot achieve.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method performs preliminary actions by first establishing central nervous tissue (specifically hypothalamus) within the aggregate before inducing ectodermal differentiation. This preliminary neural tissue formation creates the necessary inductive environment that triggers subsequent pituitary precursor tissue development, a sequence that conventional methods lack.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If dispersed floating-culture method is used, then nerve differentiation is induced, but homogeneous aggregate formation and simultaneous ectoderm differentiation are not achieved

Engineering Contradiction:
ImproveDifferentiation speedVSAvoidTissue homogeneity and organization
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The method merges neural differentiation and ectodermal differentiation processes within a single aggregate structure. By combining these previously separate differentiation pathways into one integrated system, the method achieves simultaneous development of both central nervous tissue and non-neural head ectoderm, enabling pituitary precursor tissue formation that requires interaction between both tissue types.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The method changes key culture parameters by using homogeneous aggregates instead of dispersed cells, and by controlling the timing and concentration of signaling molecules (such as BMPs and Shh) to sequentially induce different tissue types. These parameter changes enable both high differentiation speed and precise tissue organization.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If no specific signal promoters are used, then simple neural differentiation occurs, but organized hypothalamus and ectoderm tissue formation with pituitary induction is not achieved

Engineering Contradiction:
ImproveCulture process simplicityVSAvoidSignal pathway control requirements
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The method uses specific signal promoters (such as BMPs for ectodermal differentiation and Shh for neural differentiation) as intermediaries that mediate the complex interactions required for pituitary precursor tissue formation. These signaling molecules act as controlled mediators between different cell populations within the aggregate, enabling organized tissue formation without requiring complex external manipulation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS11834672B2Method for producing hypophysis precursor tissue
Publication Date: 2023.12.05 RIKEN CO LTD
  • US11834672B2 patent drawing
  • US11834672B2 patent drawing
  • US11834672B2 patent drawing

AI summary

The present invention provides a method of obtaining aggregates containing a rostral hypothalamus tissue and a rostral head ectodermal tissue, a hypophysis precursor tissue and a hypophysis hormone producing cell, by using a serum-free medium (preferably substantially free of growth factor and insulins), forming homogeneous aggregates of stem cells from pluripotent stem cells such as ES cell and the like, which are plated at a high cell concentration, and subjecting the formed aggregates to floating-culture.